Angina or ischemia with no obstructed coronary arteries: a specific diagnostic and therapeutic protocol

Riccardo Rinaldi, F. Spione, Filippo Maria Verardi, Pablo Vidal Calés, V. Arévalos, R. Gabani, Daniel Cánovas, Montserrat Gutiérrez, Montserrat Pardo, Rosa Domínguez, Luis Pintor, Xavier Torres, X. Freixa, A. Regueiro, Omar Abdul-Jawad Altisent, Manel Sabaté, and, Salvatore Brugaletta
{"title":"Angina or ischemia with no obstructed coronary arteries: a specific diagnostic and therapeutic protocol","authors":"Riccardo Rinaldi, F. Spione, Filippo Maria Verardi, Pablo Vidal Calés, V. Arévalos, R. Gabani, Daniel Cánovas, Montserrat Gutiérrez, Montserrat Pardo, Rosa Domínguez, Luis Pintor, Xavier Torres, X. Freixa, A. Regueiro, Omar Abdul-Jawad Altisent, Manel Sabaté, and, Salvatore Brugaletta","doi":"10.24875/recice.m23000418","DOIUrl":null,"url":null,"abstract":"Introduction and objectives : A systematic approach to patients with angina with no obstructed coronary arteries (ANOCA) or ischemia with no obstructed coronary arteries (INOCA) patients is not routinely implemented. Methods: All consecutive patients diagnosed with ANOCA/INOCA were referred to a designated outpatient clinic for a screening visit to assess their eligibility for a NOCA program. If eligible, patients underwent scheduled coronary angiograms with coronary function testing and intracoronary acetylcholine provocation testing. Medical therapy was optimized accordingly. All patients were then followed up at 1, 3, 6, and 12 months. Baseline and 3-month follow-up assessments included the Seattle Angina Questionnaire (SAQ) and EuroQol-5D questionnaire. Results: Of 77 patients screened, 23 (29.9%) were excluded and 54 (70.1%) were included (29 [53.7%] with INOCA and 25 [46.3%] with ANOCA). Microvascular angina was diagnosed in 19 (35.2%) patients, vasospastic angina in 12 (22.2%), both microvascular angina and vasospastic angina in 18 (33.3%), and noncoronary chest pain in 5 (9.3%). There was a notable increase in the use of beta-blockers, calcium channel blockers and nitrates. Complications occurred in 3 (5.5%) patients. Compared with baseline, there was no difference in the mean EQ-5D score at the 3-month follow-up, but there was a significant improvement in the SAQ score related to physical limitations, angina stability, and disease perception, with no differences in angina frequency or treatment satisfaction. No events were recorded at the 1-year follow-up. Conclusions: A specific diagnostic and therapeutic protocol can be easily and safely implemented in routine clinical practice, leading to improvement in patients’ quality of life.","PeriodicalId":509332,"journal":{"name":"REC: interventional cardiology (English Edition)","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"REC: interventional cardiology (English Edition)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24875/recice.m23000418","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction and objectives : A systematic approach to patients with angina with no obstructed coronary arteries (ANOCA) or ischemia with no obstructed coronary arteries (INOCA) patients is not routinely implemented. Methods: All consecutive patients diagnosed with ANOCA/INOCA were referred to a designated outpatient clinic for a screening visit to assess their eligibility for a NOCA program. If eligible, patients underwent scheduled coronary angiograms with coronary function testing and intracoronary acetylcholine provocation testing. Medical therapy was optimized accordingly. All patients were then followed up at 1, 3, 6, and 12 months. Baseline and 3-month follow-up assessments included the Seattle Angina Questionnaire (SAQ) and EuroQol-5D questionnaire. Results: Of 77 patients screened, 23 (29.9%) were excluded and 54 (70.1%) were included (29 [53.7%] with INOCA and 25 [46.3%] with ANOCA). Microvascular angina was diagnosed in 19 (35.2%) patients, vasospastic angina in 12 (22.2%), both microvascular angina and vasospastic angina in 18 (33.3%), and noncoronary chest pain in 5 (9.3%). There was a notable increase in the use of beta-blockers, calcium channel blockers and nitrates. Complications occurred in 3 (5.5%) patients. Compared with baseline, there was no difference in the mean EQ-5D score at the 3-month follow-up, but there was a significant improvement in the SAQ score related to physical limitations, angina stability, and disease perception, with no differences in angina frequency or treatment satisfaction. No events were recorded at the 1-year follow-up. Conclusions: A specific diagnostic and therapeutic protocol can be easily and safely implemented in routine clinical practice, leading to improvement in patients’ quality of life.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
无冠状动脉阻塞的心绞痛或心肌缺血:特定的诊断和治疗方案
导言和目的:冠状动脉无阻塞性心绞痛(ANOCA)或冠状动脉无阻塞性心肌缺血(INOCA)患者的系统治疗方法尚未常规实施。方法:所有被诊断为 ANOCA/INOCA 的连续患者都会被转诊到指定门诊进行筛查,以评估他们是否符合 NOCA 计划的要求。如果符合条件,患者将按计划接受冠状动脉造影、冠状动脉功能测试和冠状动脉内乙酰胆碱激发试验。医学治疗也相应进行了优化。随后,对所有患者进行了 1、3、6 和 12 个月的随访。基线和 3 个月随访评估包括西雅图心绞痛问卷 (SAQ) 和 EuroQol-5D 问卷。结果:在筛选出的 77 名患者中,23 人(29.9%)被排除,54 人(70.1%)被纳入(29 人[53.7%]患有 INOCA,25 人[46.3%]患有 ANOCA)。19(35.2%)名患者被诊断为微血管性心绞痛,12(22.2%)名患者被诊断为血管痉挛性心绞痛,18(33.3%)名患者同时被诊断为微血管性心绞痛和血管痉挛性心绞痛,5(9.3%)名患者被诊断为非冠状动脉性胸痛。β-受体阻滞剂、钙通道阻滞剂和硝酸盐的使用明显增加。有 3 名患者(5.5%)出现并发症。与基线相比,3 个月随访时的平均 EQ-5D 得分没有差异,但与身体限制、心绞痛稳定性和疾病感知相关的 SAQ 得分有显著改善,心绞痛频率和治疗满意度没有差异。1 年随访中未记录任何事件。结论在常规临床实践中可以轻松安全地实施特定的诊断和治疗方案,从而改善患者的生活质量。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Practical concepts of catheter-directed aspiration thrombectomy in ECMO-supported patients Inception of the coronary stent: a story of successful collaboration between innovative scientists and the biotechnology industry Role of computed tomography in transcatheter coronary and structural heart disease interventions Spanish cardiac catheterization in congenital heart diseases registry. Third official report from the ACI-SEC and the GTH-SECPCC (2022) Safety and efficacy of the Essential Pro paclitaxel drug-eluting balloon for the treatment of coronary in-stent restenosis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1